Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits
Biogerontology · 2025
DOI: 10.1007/s10522-025-10320-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biogerontology, 2025. Verfasst von Maanya Vittal und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK. M.Vittal@ljmu.ac.uk. Hauptthemen laut MEDLINE: Withania, Plant Extracts, Healthy Aging, Longevity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ashwagandha ( Withania somnifera ), a revered herb in Ayurvedic medicine, has gained significant scientific recognition for its potential to promote healthy aging. Traditionally used as a Rasayana or rejuvenator, this potent adaptogen helps the body manage stress and enhance vitality. This review synthesises extensive evidence for its multifaceted anti-aging capabilities, which target key hallmarks of the aging process. The mechanisms underpinning its effects include enhancing telomerase activity to support cellular longevity, combating systemic oxidative stress, and powerfully countering inflammaging by modulating immune responses and lowering inflammatory markers like C-reactive protein. Robust clinical evidence demonstrates its efficacy in improving crucial physiological parameters, including significant gains in muscle strength and size, enhanced cardiorespiratory fitness, hormonal balance, skin health, and improved sleep quality in older adults. Furthermore, trials have consistently shown its ability to improve cognitive function, including memory and information-processing speed, particularly in adults with mild cognitive impairment. Promising preclinical data also highlight its neuroprotective potential in models of Alzheimer’s and Parkinson’s disease. Here, we review the current evidence supports Ashwagandha’s therapeutic potential in extending healthspan and enhancing quality of life. Large-scale, long-term clinical trials using standardized extracts are essential to fully confirm its role in healthy aging within the global population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK. M.Vittal@ljmu.ac.uk.
- School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK. m.vinciguerra@ljmu.ac.uk.
- Department of Stem Cell Biology, Research Institute, Medical University, Varna, Bulgaria. m.vinciguerra@ljmu.ac.uk.
ORCID-Profile: Maanya Vittal, Manlio Vinciguerra
Zitieren
APA
Vittal, M., & Vinciguerra, M. (2025). Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits. Biogerontology. https://doi.org/10.1007/s10522-025-10320-0
Vancouver
Vittal M, Vinciguerra M. Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits. Biogerontology. 2025. doi:10.1007/s10522-025-10320-0
BibTeX
@article{Vittal2025,
author = {Vittal, Maanya and Vinciguerra, Manlio},
title = {Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits},
journal = {Biogerontology},
year = {2025},
doi = {10.1007/s10522-025-10320-0}
}
EUVIMED